Birth cohort effects in adults associated with influenza A(H1N1)pdm09 vaccine effectiveness

Clicks: 3
ID: 316408
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #331 of 432 articles by views in The Journal of infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
BACKGROUND: In the 2023-24 influenza season, adults born in the 1957-1985 birth cohort had the lowest vaccine effectiveness (VE) against A(H1N1)pdm09 viruses than other age groups, including those in the 1986-2005 birth cohort. Here, we investigated A(H1N1)pdm09 antibody levels in sera collected from influenza cases and controls to explain the birth cohort effect of the low VE. METHODS: Acute sera within 7 days and convalescent sera at 28 days post-symptom onset were collected from adult patients (18-66 years, 1986-2005 and 1957-1985 birth cohorts) enrolled in the US Influenza VE Network study during the 2023-2024 season. Hemagglutination inhibiting (HI) antibodies and binding antibodies in sera were assessed against representative A(H1N1) viruses and hemagglutinin antigens. RESULTS: A(H1N1)pdm09-infected cases in the 1957-1985 birth cohort had significantly lower HI antibodies in the acute sera against circulating A(H1N1)pdm09 viruses in 2023-24 season than those born in 1986-2005. Over 60% of the cases in the 1957-1985 birth cohort had HI antibodies ≤10 to the circulating A(H1N1)pdm09 viruses. Nonetheless, vaccinated cases in the same 1957-1985 birth cohort were able to mount robust antibody responses to A(H1N1)pdm09 virus infection, suggesting low vaccine immunogenicity. Antibody landscape analysis by both HI and binding antibodies revealed that these patients born in 1957-1985 with the lowest VE were likely primed with USSR/77-like A(H1N1) viruses. CONCLUSION: HI antibody levels in the acute sera around the time of encountering influenza viruses were associated with protection against influenza A(H1N1)pdm09 infection. Improving immunogenicity of the vaccines could help improve VE and overcome the birth cohort effects.
Reference Key
openalex_W7163940086 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Feng Liu, F Liaini Gross, Zhunan Li, Stacey L. House, Tamair Curley, Elie Saade, Zainab Albar, Richard K Zimmerman, Mary Patricia Nowalk, Manjusha Gaglani, Spencer Rose, Vel Murugan, Bradley Bobbett, Emily T Martin, Ivana A. Vaughn, Karen J. Wernli, Erika Kiniry, Emmanuel B Walter, Olivia L. Williams, Lauren Grant, Emma K Noble, Kelsey M. Sumner, Ashley M Price, Brendan Flannery, Jessie R Chung, Min Z. Levine, US Flu VE Network Investigators, Kelly Conard, Izamar Garcia, Lucy Sublasky-Rodriguez, Joshua Jackson, Ian Schamburg, Michael Lehmkuhl, Natalie A B Bontrager, Curtis Donskey, Kiran A. Faryar, David Canaday, Krissy Moehling Geffel, Louise Taylor, Megan Culler Freeman, Kempapura Murthy, Michael Smith, Chandni Raiyani, C Hallie Phillips, Brianna Wickersham, Matthew Nguyen, Arnold Monto, Aleda Leis
Journal The Journal of infectious diseases
Year 2026
DOI
10.1093/infdis/jiag294
URL
https://doi.org/10.1093/infdis/jiag294
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.